End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,757 KRW | +0.34% | -4.77% | -53.27% |
06-10 | Shaperon and Dong-A St Sign MOU for Nanobody-Based New Drug Development | CI |
03-18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
29.24M | - | - | - | - | - | |
122B | ||||||
113B | ||||||
26.49B | - | |||||
19.4B | - | |||||
16.24B |
- Stock Market
- Equities
- A378800 Stock
- Charts Shaperon Inc.
- Sector Chart